Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT

McLornan, Donal P. and Szydlo, Richard and Robin, Marie and van Biezen, Anja and Koster, Linda and Blok, Henrik J. P. and Van Lint, Maria T. and Finke, Juergen and Vitek, Antonin and Carlson, Kristina and Griskevicius, Laimonas and Holler, Ernst and Itala-Remes, Maija and Schaap, Michel and Socie, Gerard and Bay, Jacques-Olivier and Beguin, Yves and Bruno, Benedetto and Cornelissen, Jan J. and Gedde-Dahl, Tobias and Ljungman, Per and Rubio, Marie T. and Yakoub-Agha, Ibrahim and Klyuchnikov, Evgeny and Olavarria, Eduardo and Chalandon, Yves and Kroeger, Nicolaus (2018) Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT. BRITISH JOURNAL OF HAEMATOLOGY, 182 (3). pp. 418-422. ISSN 0007-1048, 1365-2141

Full text not available from this repository. (Request a copy)

Abstract

Allogeneic Haematopoietic Stem Cell Transplant (allo-HSCT) remains the only curative approach for Myelofibrosis (MF). Scarce information exists in the literature on the outcome and, indeed, management of those MF patients who relapse following transplant. We hereby report on the management and outcome of 202 patients who relapsed post allo-HSCT for MF.

Item Type: Article
Uncontrolled Keywords: ; mylelofibrosis; allogeneic stem cell transplant; fibrosis; JAK inhibitors; relapse
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User: Dr. Gernot Deinzer
Date Deposited: 06 Mar 2020 06:29
Last Modified: 06 Mar 2020 06:29
URI: https://pred.uni-regensburg.de/id/eprint/14178

Actions (login required)

View Item View Item